(-0.05%) 5 305.75 points
(-0.02%) 40 136 points
(-0.06%) 18 493 points
(1.18%) $82.31
(-1.22%) $1.697
(1.87%) $2 231.60
(0.02%) $24.76
(0.13%) $910.85
(0.36%) $0.927
(0.58%) $10.83
(0.14%) $0.792
(-0.25%) $92.21
Live Chart Being Loaded With Signals
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States...
Stats | |
---|---|
Today's Volume | 2.29M |
Average Volume | 2.47M |
Market Cap | 29.31M |
EPS | $0 ( 2024-02-09 ) |
Next earnings date | ( $-0.330 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.460 |
ATR14 | $0.00100 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Do Cuong V | Buy | 10 000 | Common stock |
2024-03-04 | Do Cuong V | Buy | 5 000 | Warrants (right to buy) |
2023-12-11 | Kim Joanne Wendy | Buy | 5 000 | Common Stock |
2023-11-09 | Lang James Paul | Buy | 93 500 | Stock Option (right to buy) |
2023-11-09 | Gorlin Steve | Buy | 46 358 | Common Stock |
INSIDER POWER |
---|
92.55 |
Last 94 transactions |
Buy: 39 235 676 | Sell: 4 917 434 |
Volume Correlation
Biovie Inc Correlation
10 Most Negative Correlations | |
---|---|
DBX | -0.895 |
RMRM | -0.894 |
PCT | -0.882 |
PTC | -0.866 |
NOVT | -0.864 |
OPEN | -0.861 |
CVAC | -0.846 |
XP | -0.845 |
FTHM | -0.842 |
EXPI | -0.842 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biovie Inc Correlation - Currency/Commodity
Biovie Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-266 842 (0.00 %) |
EPS: | $-1.550 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-67 104.00 (0.00 %) |
EPS: | $-0.250 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-66 833.00 (0.00 %) |
EPS: | $-0.430 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-66 577.00 (0.00 %) |
EPS: | $-0.610 |
Financial Reports:
No articles found.
Biovie Inc
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Carson City, Nevada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators